Publications by authors named "Zhenmou Xie"
Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy.
Ann Clin Microbiol Antimicrob
June 2024
Article Synopsis
- Chromoblastomycosis (CBM) is a chronic fungal skin infection caused mainly by dematiaceous fungi in tropical and subtropical regions, leading to plaques and scarring after healing.
- Diagnosis can be enhanced with traditional methods like microscopy and culture, along with advanced techniques like dermatoscopy and reflectance confocal microscopy.
- A case study from Guangdong shows successful management of CBM using a combination of itraconazole, terbinafine, and imiquimod, emphasizing new treatment strategies for this difficult condition.
Chromoblastomycosis (CBM) is a chronic disease caused by several species of dematiaceous fungi. In this study, a regional collection of 45 CBM cases was conducted in Guangdong, China, a hyper-endemic area of CBM. Epidemiology findings indicated that the mean age of cases was 61.
View Article and Find Full Text PDFA microdilution method for the antibiotic susceptibility testing of Neisseria gonorrhoeae was established and improved, and the antibiotic resistance of N. gonorrhoeae samples isolated from 8 cities of Guangdong in 2016 was determined. The improved microdilution method was compared with the agar dilution method recommend by the World Health Organization (WHO) Western Pacific Region by testing the susceptibility of 100 clinical N.
View Article and Find Full Text PDF